Top Markets
Coin of the day
Holy Stone Healthcare Co., Ltd. Holy Stone Healthcare Co., Ltd.

Holy Stone Healthcare Co., Ltd.

4194
Rangering i aksjer #27776
Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and... Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis and SportVis, which are injectable medical devices for osteoarthritis and soft tissue injuries; TRUD, a medical device that contains a mixture of hyaluronic acid used for the treatment and prevention of ulcerative colitis in inflammatory bowel disease (IBD); and GAF, a gel for anal fissure healing. It also develops IBD98-M, an oral capsule that is in a Phase IIa trial for ulcerative colitis; CA102N, a receptor-targeted chemotherapy that is in a Phase II trial for metastatic colorectal cancer, as well as in a pre-clinical stage for pancreatic ductal adenocarcinoma and a discovery stage for triple-negative breast cancer; ND108E, a CNS-targeted HA conjugate that is in a pre-clinical trial for Alzheimer’s disease; AMD112, a non-invasive HA-conjugated small molecule therapy that is in a pre-clinical trial for wet age-related macular degeneration and other neovascular retinal diseases; and HylCaryo, a hyaluronic acid (HA)-derived nanoparticle platform in a discovery stage. In addition, the company engages in general investment; development and sale of medical devices; biotechnology services; and patent application for pharmaceutical products. Holy Stone Healthcare Co., Ltd. was founded in 2001 and is headquartered in Taipei, Taiwan.
Aksjekurs
$0.20478574
Markedsverdi
$29.89M
Endring (1 dag)
2.38%
Endring (1 år)
-43.60%
Land
TW
Handel Holy Stone Healthcare Co., Ltd. (4194)

Kategori

Aksjeprishistorikk for Holy Stone Healthcare Co., Ltd. (4194)
Høyeste sluttskurs: $0.20 den 2026-08-01

Laveste sluttskurs: $3.08 den 2013-12-01
Aksjeprishistorikk for Holy Stone Healthcare Co., Ltd. fra 2013 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -0.29%
2025 -34.97%
2024 -38.74%
2023 -35.18%
2022 1.68%
2021 0.68%
2020 168.94%
2019 -26.05%
2018 -12.91%
2017 -1.95%
2016 -46.23%
2015 -26.48%
2014 -52.19%
2013 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$61.63 67.11%
US
$52.00 75.53%
SE
$195.83 45.38%
FR
$119.62 69.92%
US
$62.93 2.96%
IT